Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score

被引:32
作者
Huo, TI [1 ]
Lin, HC
Lee, FY
Hou, MC
Lee, PC
Wu, JC
Chang, FY
Lee, SD
机构
[1] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan
[2] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan
[3] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan
关键词
esophageal varices; hepatic encephalopathy; liver cirrhosis; liver transplantation; MELD; spontaneous bacterial peritonitis;
D O I
10.1111/j.1478-3231.2005.01190.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The model for end-stage liver disease (MELD) is used to prioritize cirrhotic patients awaiting liver transplantation. Many cirrhosis-related complications are indications for transplantation but are not included in MELD. This study investigated the impact of these complications on survival and association with MELD. Methods: The mortality risk of cirrhosis-related complications, including bleeding esophageal varices. spontaneous bacterial peritonitis, hepatic encephalopathy, hepatorenal syndrome and hepatic decompensation, was analyzed using a time-dependent Cox regression model in 227 cirrhotic patients. Results: A total of 281 episodes of complications occurred in 142 (63%) patients. Patients who died had a significantly higher baseline MELD score compared with those who survived (14.5 +/- 4.5 vs 12.8 +/- 3.9, P=0.004). There was no significant difference in the MELD score between patients with and without the occurrence of complications (13.6 +/- 4.3 vs 12.9 +/- 4.0, P=0.093). Patients with a higher baseline MELD score tended to develop early complications (rho=-0.598, P<0.001). Using the Cox regression model, the risk ratio of mortality was 4.9 (95% confidence interval: 3.9-6.3, P<0.0001) for each additional episode of complication. Conclusions: The mortality risk increases as the number of complication episodes increases. While patients with repeated complications have a poor outcome, they do not necessarily have a higher baseline MELD score and could be down-staged in the MELD era.
引用
收藏
页码:55 / 61
页数:7
相关论文
共 31 条
[11]   Improving liver allocation: MELD and PELD [J].
Freeman, RB ;
Wiesner, RH ;
Roberts, JP ;
McDiarmid, S ;
Dykstra, DM ;
Merion, RM .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 :114-131
[12]  
Giannini E, 2003, GASTROENTEROLOGY, V125, P993, DOI 10.1016/S0016-5085(03)01147-8
[13]  
HOU MC, 1995, HEPATOLOGY, V21, P1517, DOI 10.1016/0270-9139(95)90453-0
[14]   Recurrence of esophageal varices following endoscopic treatment and its impact on rebleeding: comparison of sclerotherapy and ligation [J].
Hou, MC ;
Lin, HC ;
Lee, FY ;
Chang, FY ;
Lee, SD .
JOURNAL OF HEPATOLOGY, 2000, 32 (02) :202-208
[15]   Evaluation of the increase in model for end-stage liver disease (ΔMELD) score over time as a prognostic predictor in patients with advanced cirrhosis:: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score [J].
Huo, TI ;
Wu, JC ;
Lin, HC ;
Lee, FY ;
Hou, MC ;
Lee, PC ;
Chang, FY ;
Lee, SD .
JOURNAL OF HEPATOLOGY, 2005, 42 (06) :826-832
[16]   A model to predict survival in patients with end-stage liver disease [J].
Kamath, PS ;
Wiesner, RH ;
Malinchoc, M ;
Kremers, W ;
Therneau, TM ;
Kosberg, CL ;
D'Amico, G ;
Dickson, ER ;
Kim, WR .
HEPATOLOGY, 2001, 33 (02) :464-470
[17]  
Lucey M R, 1998, Transplantation, V66, P956, DOI 10.1097/00007890-199810150-00034
[18]   Longitudinal assessment of mortality risk among candidates for liver transplantation [J].
Merion, RM ;
Wolfe, RA ;
Dykstra, DM ;
Leichtman, AB ;
Gillespie, B ;
Held, PJ .
LIVER TRANSPLANTATION, 2003, 9 (01) :12-18
[19]   Hepatic encephalopathy [J].
Ong, JP ;
Mullen, KD .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2001, 13 (04) :325-334
[20]  
Preneta E, 1998, HEPATOLOGY, V28, p453A